(Dharshini.G, Intern journalist) New Delhi : A 30-year-old person was on Friday given the first dosage of undertrial coronavirus immunization Covaxin at Delhi’s All India Institute Of Medical Sciences (AIIMS). An aggregate of 12 volunteers were required various pre-tests that incorporate blood and nasopharyngeal testing for COVID-19.

After test results, 10 sound people were chosen for the immunization to be given in stages.After the first dosage, a report on their health condition will be submitted to the ethics council, which will go through the whole procedure.100 sound individuals will be vaccinated at AIIMS during these tests.

Covaxin, created by Hyderabad-based Bharat Biotech as a team with the ICMR and the National Institute of Virology (NIV), had as of now got the approval for human clinical preliminaries from the Drugs Controller General of India (DCGI).

AIIMS-Delhi is among the 12 establishments chose by the Indian Council for Medical Research (ICMR) for directing the initial two phases of the randomized,double blind, placebo controlled clinical preliminaries of Covaxin.

About Post Author